Daily Stock Analysis, CDXS, Codexis Inc, priceseries

Codexis Inc. Daily Stock Analysis
Stock Information
Open
19.45
Close
18.69
High
19.78
Low
18.57
Previous Close
19.30
Daily Price Gain
-0.61
YTD High
32.28
YTD High Date
Jan 3, 2022
YTD Low
16.60
YTD Low Date
Feb 24, 2022
YTD Price Change
-13.24
YTD Gain
-41.47%
52 Week High
42.01
52 Week High Date
Nov 8, 2021
52 Week Low
16.55
52 Week Low Date
May 11, 2021
52 Week Price Change
0.61
52 Week Gain
3.37%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 7. 2017
6.85
Jan 3. 2018
8.10
17 Trading Days
18.31%
Link
LONG
Feb 14. 2018
8.65
Mar 9. 2018
10.00
16 Trading Days
15.61%
Link
LONG
May 11. 2018
12.65
Jun 8. 2018
14.75
19 Trading Days
16.61%
Link
LONG
Aug 17. 2018
15.05
Sep 19. 2018
17.89
22 Trading Days
18.84%
Link
LONG
Nov 21. 2018
17.42
Dec 11. 2018
20.82
12 Trading Days
19.52%
Link
LONG
Jan 29. 2019
16.99
Feb 27. 2019
21.41
20 Trading Days
26.02%
Link
LONG
Nov 1. 2019
13.87
Nov 18. 2019
14.89
11 Trading Days
7.34%
Link
LONG
Jan 6. 2020
16.59
Jan 21. 2020
17.72
10 Trading Days
6.77%
Link
LONG
Aug 3. 2020
12.16
Aug 21. 2020
13.35
14 Trading Days
9.80%
Link
LONG
Oct 5. 2020
12.28
Oct 26. 2020
14.01
15 Trading Days
14.13%
Link
LONG
Nov 4. 2020
14.17
Dec 3. 2020
17.63
20 Trading Days
24.41%
Link
LONG
Dec 14. 2020
18.84
Jan 4. 2021
21.12
13 Trading Days
12.09%
Link
LONG
Jan 13. 2021
23.30
Jan 26. 2021
24.91
8 Trading Days
6.89%
Link
LONG
Aug 23. 2021
23.96
Sep 10. 2021
26.89
13 Trading Days
12.25%
Link
LONG
Oct 4. 2021
25.61
Oct 14. 2021
28.16
8 Trading Days
9.94%
Link
LONG
Oct 22. 2021
29.75
Nov 15. 2021
36.22
16 Trading Days
21.74%
Link
Company Information
Stock Symbol
CDXS
Exchange
NasdaqGS
Company URL
http://www.codexis.com
Company Phone
650-421-8100
CEO
John J. Nicols
Headquarters
California
Business Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA 94063
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001200375
About

Codexis, Inc. is a protein engineering company, which applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The company discovers, develops and sells proteins that deliver value to its clients in a growing set of industries. It provides state-of-the-art enzyme optimization services and developing biocatalyst products. The company's technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. It offers enzyme optimization and supply, from small scale through to commercial quantities. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Description

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also improves the pharmaceuticals companies manufacturing productivity and efficiency, as well as helps in outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. Further, the company develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.